Effectiveness of Vazonat in the comprehensive therapy of patients with type 2 diabetes mellitus on the background of cardiovascular disease
Journal Title: Міжнародний ендокринологічний журнал - Year 2018, Vol 14, Issue 1
Abstract
Background. In accordance with the postulates of the National Cholesterol Education Program, type 2 diabetes mellitus (DM) is classified as coronary heart disease equivalent of risk. Purpose of this work is to investigate the dynamics of anthropometric indexes, parameters of carbohydrate metabolism, markers of insulin resistance (IR), indexes of hepatic complex, coagulogram, urinary acid, glomerular filtration rate (GFR), and also instrumental indexes in patients with type 2 DM during differentiated hypoglycemic and metabolic therapy by Vazonat preparation for 6 and 9 months. Materials and methods. Under supervision, there were 60 patients with type 2 DM in the state of decompensation, who received Vazonat 10 ml intravenously as metabolic therapy during 10 days from the beginning of the research and 1000 μg/day orally for prolongation of the course during 6 and 9 months. Influence of Vazonat was studied on the background the differentiated hypoglycemic therapy: by oral hypoglycemic preparations (metformin, 30 patients), combination therapy with metformin and NPH insulin (second group, 30 individuals). Study of the dynamics of carbohydrate metabolism indexes and IR markers was conducted in patients at the beginning of the research and during 6 and 9 months. Results. Vazonat strengthens the effect of hypoglycemic therapy, influences the IR indexes and anthropometric parameters, lipidogram values, hepatic complex, urinary acid level, prothrombin index, GFR and positively influences the dynamics of left ventricular ejection fraction. Conclusions. It is expedient to prescribe Vazonat as additional metabolic therapy for the improvement of clinical course and disease prognosis, and also for the improvement of quality of life in patients with type 2 DM and hepato- and nephropathy, coronary heart disease, arterial hypertension, gout, violations of blood lipid spectrum.
Authors and Affiliations
K. Yu. Maliar, O. S. Anisimova, O. I. Drishliuk, L. Yu. Bykovska, E. V. Filipova
Keywords
Related Articles
- EP ID EP275728
- DOI 10.22141/2224-0721.14.1.2018.127098
- Views 78
- Downloads 0
The prevalence and structure of major risk factors in women with postmenopausal osteoporosis
Background. Violation of bone mineral density as a cause of disability and mortality due to fractures, according to the data of World Health Organization, rank fourth in the world in terms of the prevalence after cardiov...
Beware of Pesudohealers of Diabetes!
The article deals with pseudohealing, topical question of all medical specialities including endocrinology. Each physician knows negative consequences of pseudohealer’s actions for patients, however there are no particul...
Pathogenetic and clinical correlation of type 2 diabetes mellitus with metabolic syndrome and chronic coronary artery disease
Background. Increase of morbidity of diabetes mellitus (DM) associated with coronary artery disease (CAD) on the background of metabolic syndrome (MS) is worrisome. It is very important to improve the diagnosis of this a...
Peculiarities of changes in the coagulation and fibrinolytic activity in patients with coronary heart disease and concomitant type 2 diabetes mellitus, depending on the presence of diabetic vascular complications
Background. The purpose of this work was to study endogenous coagulation/fibrinolysis markers in patients with coronary heart disease (CHD) and concomitant type 2 diabetes mellitus (DM) and to compare these indices with...
Blood glucose level and insulin resistance in patients with type 2 diabetic mellitus, diabetic retinopathy and obesity
Background. Diabetic retinopathy is the main cause of visual disorders in the world. The purpose of our work was to study the level of glycaemia and insulin resistance in patients with type 2 diabetes mellitus (DM), diab...